(PhysOrg.com) -- Investigators at Georgia State University’s Neuroscience Institute and Center for Behavioral Neuroscience are the first to identify the most likely reason analgesic drug treatment is ...

Drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain, an international study reports, for the ...

Clinical trials of a novel non-opioid analgesic have found it to be effective in reducing acute postoperative pain, opening the door to a new way of managing short-term pain that avoids the pitfalls ...

A February 2015 report from the Centers for Disease Control and Prevention provided updated estimates of prescription opioid analgesic use among adults ages 20 and over. The authors concluded that ...

Oncode Investigator Mario van der Stelt and his lab discovered a potential new drug that suppresses chemotherapy-induced neuropathic pain. The results are published in Nature Communications. Despite ...

Mild analgesics (hereafter, analgesics) consisting of paracetamol and NSAIDs are among the most used pharmaceutical drugs worldwide as well as the most released into the environment Epidemiological ...

Virtually all new analgesics approved over the past 25 years are derivatives or reformulations of opioids or aspirin-like drugs, existing drugs given for a new indication or older drugs given by a ...

NEW YORK (Reuters Health) - The regular use of over-the-counter analgesic drugs, such as aspirin and ibuprofen, does not appear to reduce the risk of ovarian cancer, according to findings published in ...

Share on Pinterest A recent study used computational methods to identify novel compounds that activate receptors involved in pain modulation without sedation. Peter Dazeley/Getty Images Research on ...

The objective of this cross-sectional, noninterventional, 6-month observational study was to assess the adequacy of pain management in patients with cancer admitted to the Oncology Department of Guru ...

BMC Clin Pharmacol. 2010;10:1-23. This study aimed to evaluate the impact of the withdrawal of distalgesic from the Irish market in terms of intentional drug overdose (IDO) presentations to hospital ...

Investigators have identified the most likely reason analgesic drug treatment is usually less potent in females than males. This discovery is a major step toward finding more effective treatments for ...